In addition, BCR::ABL1 quantification in Philadelphia chromosome-positive ALL and KMT2A-rearrangements in infant ALL were added to the EuroMRD portfolio in 2008 [9]. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.